| Trial ID: | L7080 |
| Source ID: | NCT00865397
|
| Associated Drug: |
Insulin Detemir
|
| Title: |
Observational Study in Type 2 Diabetics Failing on Oral Antidiabetic Therapy and Starting on Insulin Treatment
|
| Acronym: |
HA-BOT
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes|Diabetes Mellitus, Type 2
|
| Interventions: |
DRUG: insulin detemir
|
| Outcome Measures: |
Primary: Change in HbA1c, after 24 weeks | Secondary: Percentage of subjects to reach HbA1c below 7.0% and equal to or more than 6.5%, after 12 weeks and 24 weeks|Change in FPG (Fasting Plasma Glucose), after 12 weeks and 24 weeks|Change in body weight, after 12 weeks and 24 weeks|Change in waist and hip circumference, after 12 weeks and 24 weeks
|
| Sponsor/Collaborators: |
Sponsor: Novo Nordisk A/S
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
1032
|
| Study Type: |
OBSERVATIONAL
|
| Study Designs: |
Observational Model: |Time Perspective: p
|
| Start Date: |
2009-02
|
| Completion Date: |
2010-05
|
| Results First Posted: |
|
| Last Update Posted: |
2016-11-23
|
| Locations: |
Novo Nordisk Investigational Site, Budapest, 1025, Hungary|Novo Nordisk Investigational Site, Budapest, H-1025, Hungary
|
| URL: |
https://clinicaltrials.gov/show/NCT00865397
|
